Echinococcus multilocularis in Dogs, Japan
To the Editor: Alveolar echinococcosis in humans is endemic in Japan; however, the causal agent, Echinococcus multilocularis, has been restricted to the northernmost insular prefecture of Hokkaido, where the Tsugaru Strait acts as a natural physical barrier against migration to the mainland. Two E. multilocularis invasions into Hokkaido have occurred (1) . The first invasion to the offshore island of Rebun in the mid1920s was successfully controlled; however, the second invasion, supposedly in the 1940s, led to the current epidemic on the main island of Hokkaido. Both invasions were entirely or partly caused by humans who removed foxes from diseaseendemic areas without taking the necessary precautions.
The finding of 19 autochthonously acquired cases of alveolar echinococcosis in prefectures other than Hokkaido (2) implies that the parasite exists in other areas, although the source of infection has yet to be identified. In many countries, studies of the increased spread of the parasite have traditionally focused on the contribution of foxes (3); however, these cases may also have been spread by domestic dogs from disease-endemic areas. Dogs are susceptible to infection with the parasite from rodents. Although the prevalence of E. multilocularis among dogs in Hokkaido is certainly lower than that in foxes (4-6), dogs can traverse considerably greater distances by various modes of transport. The number of dogs that travel from Hokkaido to other prefectures has been estimated at >12,000 per year (7). Although dogs may carry the parasite to remote areas, surveys of population dynamics have not been undertaken. We therefore studied the extent of E. multilocularis infection in dogs being transported by their owners from 4 ferry ports in Hokkaido (Hakodate, Muroran, Otaru, and Tomakomai) from September 2003 through October 2004.
We tested 183 fecal samples from 41 resident (in Hokkaido) and 142 nonresident dogs. We screened for the Echinococcus-specific coproantigen by using a commercial enzyme-linked immunosorbent assay kit (CHEKITEchinotest, Bommeli Diagnostics, Liebefeld-Bern, Switzerland) and following the manufacturer's recommendations. One dog from each group had the Echinococcus coproantigen. To confirm the specificity of the results, these 2 dogs were treated with 1 oral dose of praziquantel, 5 mg/kg.
